Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels.

Dagher Z, Gerhardinger C, Vaz J, Goodridge M, Tecilazich F, Lorenzi M.

Am J Pathol. 2017 Mar;187(3):627-638. doi: 10.1016/j.ajpath.2016.11.007. Epub 2017 Feb 2.

PMID:
28162229
2.

Mast Cells Regulate Wound Healing in Diabetes.

Tellechea A, Leal EC, Kafanas A, Auster ME, Kuchibhotla S, Ostrovsky Y, Tecilazich F, Baltzis D, Zheng Y, Carvalho E, Zabolotny JM, Weng Z, Petra A, Patel A, Panagiotidou S, Pradhan-Nabzdyk L, Theoharides TC, Veves A.

Diabetes. 2016 Jul;65(7):2006-19. doi: 10.2337/db15-0340. Epub 2016 Apr 8.

3.

Defective Myogenic Response of Retinal Vessels Is Associated With Accelerated Onset of Retinopathy in Type 1 Diabetic Individuals.

Tecilazich F, Feke GT, Mazzantini S, Sobrin L, Lorenzi M.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1523-9. doi: 10.1167/iovs.15-18356.

PMID:
27035625
4.

Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype.

Leal EC, Carvalho E, Tellechea A, Kafanas A, Tecilazich F, Kearney C, Kuchibhotla S, Auster ME, Kokkotou E, Mooney DJ, LoGerfo FW, Pradhan-Nabzdyk L, Veves A.

Am J Pathol. 2015 Jun;185(6):1638-48. doi: 10.1016/j.ajpath.2015.02.011. Epub 2015 Apr 11.

5.

Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers.

Tecilazich F, Dinh T, Pradhan-Nabzdyk L, Leal E, Tellechea A, Kafanas A, Gnardellis C, Magargee ML, Dejam A, Toxavidis V, Tigges JC, Carvalho E, Lyons TE, Veves A.

PLoS One. 2013 Dec 16;8(12):e83314. doi: 10.1371/journal.pone.0083314. eCollection 2013.

6.

Molecular biomarkers of vascular dysfunction in obstructive sleep apnea.

Kaczmarek E, Bakker JP, Clarke DN, Csizmadia E, Kocher O, Veves A, Tecilazich F, O'Donnell CP, Ferran C, Malhotra A.

PLoS One. 2013 Jul 29;8(7):e70559. doi: 10.1371/journal.pone.0070559. Print 2013.

7.

Pilot study of the effects of bariatric surgery and continuous positive airway pressure treatment on vascular function in obese subjects with obstructive sleep apnoea.

Bakker JP, Balachandran JS, Tecilazich F, Deyoung PN, Smales E, Veves A, Malhotra A.

Intern Med J. 2013 Sep;43(9):993-8. doi: 10.1111/imj.12224.

8.

The evolving natural history of neurophysiologic function in patients with well-controlled diabetes.

Gibbons CH, Freeman R, Tecilazich F, Dinh T, Lyons TE, Gnardellis C, Veves A.

J Peripher Nerv Syst. 2013 Jun;18(2):153-61. doi: 10.1111/jns5.12021.

9.

Emerging drugs for the treatment of diabetic ulcers.

Tecilazich F, Dinh TL, Veves A.

Expert Opin Emerg Drugs. 2013 Jun;18(2):207-17. doi: 10.1517/14728214.2013.802305. Epub 2013 May 21. Review.

10.

Aliskiren improves vascular smooth muscle function in the skin microcirculation of type 2 diabetic patients with normal renal function.

Dushay JR, Tecilazich F, Kafanas A, Magargee ML, Auster ME, Gnardellis C, Dinh T, Veves A.

J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):344-52. doi: 10.1177/1470320313489060. Epub 2013 May 13.

11.

Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications.

Tecilazich F, Dinh T, Lyons TE, Guest J, Villafuerte RA, Sampanis C, Gnardellis C, Zuo CS, Veves A.

J Vasc Surg. 2013 Apr;57(4):997-1005. doi: 10.1016/j.jvs.2012.10.011. Epub 2013 Mar 7.

12.

Increased skin inflammation and blood vessel density in human and experimental diabetes.

Tellechea A, Kafanas A, Leal EC, Tecilazich F, Kuchibhotla S, Auster ME, Kontoes I, Paolino J, Carvalho E, Nabzdyk LP, Veves A.

Int J Low Extrem Wounds. 2013 Mar;12(1):4-11. doi: 10.1177/1534734612474303. Epub 2013 Feb 26.

13.

Mechanisms involved in the development and healing of diabetic foot ulceration.

Dinh T, Tecilazich F, Kafanas A, Doupis J, Gnardellis C, Leal E, Tellechea A, Pradhan L, Lyons TE, Giurini JM, Veves A.

Diabetes. 2012 Nov;61(11):2937-47. doi: 10.2337/db12-0227. Epub 2012 Jun 11.

14.

Cutaneous alterations in diabetes mellitus.

Tecilazich F, Kafanas A, Veves A.

Wounds. 2011 Jul;23(7):192-203.

PMID:
25879173
15.

Treating diabetic ulcers.

Tecilazich F, Dinh T, Veves A.

Expert Opin Pharmacother. 2011 Mar;12(4):593-606. doi: 10.1517/14656566.2011.530658. Epub 2011 Jan 18. Review.

PMID:
21241210
16.

[Medical care of infants on shipboard].

Tecilazich F.

Ann Med Nav (Roma). 1971 Jan-Feb;76(1):129-31. Italian. No abstract available.

PMID:
4996575
17.

[Pyloric disease in infants. (Considerations on diagnosis and medical treatment)].

Tecilazich F.

Minerva Med. 1970 Aug 29;61(69):3578-81. Italian. No abstract available.

PMID:
5506413
18.

[The sense organs in the infantile age. Conclusions].

Tecilazich F.

Minerva Nipiol. 1969 May-Jun;19(3):264-6. Italian. No abstract available.

PMID:
5785052
19.

[The sense organs in the infantile age].

Tecilazich F.

Minerva Nipiol. 1969 May-Jun;19(3):219-21. Italian. No abstract available.

PMID:
5785047
20.

[Prophylactic vaccinations in infancy].

Tecilazich F.

Minerva Nipiol. 1968 Nov-Dec;18(6):165-6. Italian. No abstract available.

PMID:
5746847

Supplemental Content

Loading ...
Support Center